-
Study aim
-
Comparison of success rate of AGV surgery with and without Adjunctive 5-fluorouracil treatment in patients with neovascular glaucoma
-
Design
-
Clinical trial study with two parallel groups, randomized using computer permuted block randomization, 35 patients in each group are included and followed up for at least 6 months.
-
Settings and conduct
-
This study will be performed on patients with neovascular glaucoma requiring shunt surgery who are referred to the glaucoma clinic of Rasoul Akram Hospital. Patients after randomization are divided into two groups. In the shunt surgery group alone, Ahmed shunt implanted in the superotemporal area at a distance of 10 mm from the limbus. In the shunt surgery with 5FU injection group, In addition to the shunt implantation in the previous method, 5FU is injected in the first, third and fifth weeks of follow-up. Patients are then examined regularly to evaluate the success and complications of treatment.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Patients with neovascular glaucoma who require implant Ahmed shunt to control ocular pressure.
Exclusion criteria: No Light Perception patients, age less than 18 years, history of any type of eye surgery including previous glaucoma and retinal surgeries (except uncomplicated cataract surgery), history of cyclodestructive procedures, pregnant patients.
-
Intervention groups
-
Patients with neovascular glaucoma are divided into two groups. In one group, patients underwent Ahmed shunt surgery and in the other group, patients underwent Ahmed shunt surgery with 5FU injection.
-
Main outcome variables
-
Success rate, incidence of hypertensive phase, complications, intraocular pressure before and after surgery, number of medication used before and after surgery.